corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8994

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: book

Moore DA, Cain DM, Loewenstein G, Bazerman MH.
Conflicts of Interest: Challenges and Solutions in Business, Law, Medicine, and Public Policy
New York: Cambridge University Press 2005
http://www.cambridge.org/catalogue/catalogue.asp?isbn=9780511128370&ss=fro


Abstract:

This collection explores the subject of conflicts of interest. It investigates how to manage conflicts of interest, how they can affect well-meaning professionals, and how they can limit the effectiveness of corporate boards, undermine professional ethics, and corrupt expert opinion. Legal and policy responses are considered, some of which (e.g., disclosure) are shown to fail and even backfire. The results offer a sobering prognosis for professional ethics and for anyone who relies on professionals who have conflicts of interest. The contributors are leading authorities on the subject in the fields of law, medicine, management, public policy, and psychology. The nuances of the problems posed by conflicts of interest will be highlighted for readers in an effort to demonstrate the many ways that structuring incentives can affect decision making and organizations’ financial well-being.

Some of the papers were prepared for presentation at the Conference on Conflicts of Interest in Organizations.

Contents

List of Contributors page ix
Acknowledgments xi Introduction 1 Don A. Moore, George Loewenstein, Daylian M. Cain, and Max H. Bazerman
PART ONE BUSINESS
1 Managing Conflicts of Interest within Organizations: Does Activating Social Values Change the Impact of Self-Interest on Behavior? 13 Tom R. Tyler
2 Commentary: On Tyler’s “Managing Conflicts of Interest within Organizations” 36 Robyn Dawes
3 A Review of Experimental and Archival Conflicts-of-Interest Research in Auditing 41 Mark W. Nelson
4 Commentary: Conflicts of Interest in Accounting 70 Don A. Moore
5 Bounded Ethicality as a Psychological Barrier to Recognizing Conflicts of Interest 74 Dolly Chugh, Max H. Bazerman, and Mahzarin R. Banaji
6 Commentary: Bounded Ethicality and Conflicts of Interest 96 Ann E. Tenbrunsel
7 Coming Clean but Playing Dirtier: The Shortcomings of Disclosure as a Solution to Conflicts of Interest 104 Daylian M. Cain, George Loewenstein, and Don A. Moore
8 Commentary: Psychologically Naive Assumptions about the Perils of Conflicts of Interest 126 Dale T. Miller
PART TWO MEDICINE
9 Physicians’ Financial Ties with the Pharmaceutical Industry: A Critical Element of a Formidable Marketing Network 133 Jerome P. Kassirer
10 Commentary: How Did We Get into this Mess? 142 Peter A. Ubel
11 Why Are (Some) Conflicts of Interest in Medicine So Uniquely Vexing? 152 Andrew Stark
12 Commentary: Financial Conflicts of Interest and the Identity of Academic Medicine 181 Scott Y. H. Kim
PART THREE LAW
13 Legal Responses to Conflicts of Interest 189 Samuel Issacharoff
14 Commentary: Conflicts of Interest Begin Where Principal–Agent Problems End 202 George Loewenstein
15 Conflicts of Interest and Strategic Ignorance of Harm 206 Jason Dana
16 Commentary: Strategic Ignorance of Harm 224 Daylian M. Cain
PART FOUR PUBLIC POLICY
17 Conflicts of Interest in Public Policy Research 233 Robert J. MacCoun
18 Commentary: Conflicts of Interest in Policy Analysis: Compliant Pawns in Their Game? 263 Baruch Fischhoff
19 Conflict of Interest as an Objection to Consequentialist Moral Reasoning 270 Robert H. Frank
20 Commentary: Conflict of Interest as a Threat to Consequentialist Reasoning 284 David M. Messick
Index 289

————————————————————————————————————————

List of Contributors

Mahzarin R. Banaji
Harvard University

Max H. Bazerman
Harvard Business School

Daylian M. Cain
Carnegie Mellon University

Dolly Chugh
Harvard Business School

Jason Dana
Carnegie Mellon University

Robyn Dawes
Carnegie Mellon University

Baruch Fischhoff
Carnegie Mellon University

Robert H. Frank
Cornell University

Samuel Issacharoff
Columbia Law School

Jerome P. Kassirer
Tufts University School of Medicine

Scott Y. H. Kim
University of Michigan

George Loewenstein
Carnegie Mellon University

Robert J. MacCoun
University of California, Berkeley

David M. Messick
Northwestern University

Dale T. Miller
Stanford University

Don A. Moore
Carnegie Mellon University

Mark W. Nelson
Cornell University

Andrew Stark
University of Toronto

Ann E. Tenbrunsel
University of Notre Dame

Tom R. Tyler
New York University School of Law

Peter A. Ubel
University of Michigan

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909